Chemoinformaics analysis of Lucidinprimeveroside
| Molecular Weight | 564.496 | nRot | 6 |
| Heavy Atom Molecular Weight | 536.272 | nRig | 29 |
| Exact Molecular Weight | 564.148 | nRing | 5 |
| Solubility: LogS | -2.905 | nHRing | 2 |
| Solubility: LogP | 0.409 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 2 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 12 |
| nHA | 14 | APOL | 73.3182 |
| nHD | 8 | BPOL | 36.7698 |
| QED | 0.095 |
| Synth | 4.824 |
| Natural Product Likeliness | 1.724 |
| NR-PPAR-gamma | 0.554 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.933 |
| HIA | 0.973 |
| CACO-2 | -6.558 |
| MDCK | 0.00000723 |
| BBB | 0.091 |
| PPB | 0.903696 |
| VDSS | 0.466 |
| FU | 0.114806 |
| CYP1A2-inh | 0.041 |
| CYP1A2-sub | 0.037 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.058 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.119 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.002 |
| CL | 1.036 |
| T12 | 0.616 |
| hERG | 0.136 |
| Ames | 0.816 |
| ROA | 0.006 |
| SkinSen | 0.954 |
| Carcinogencity | 0.176 |
| EI | 0.457 |
| Respiratory | 0.054 |
| NR-Aromatase | 0.721 |
| Antiviral | Yes |
| Prediction | 0.862411 |